Last updated 2026-08-18
- Raised $30M Secondary led by Yissum, Dec 2007
- Raised $10M Seed round led by Yissum
Total raised
$40.0M
Stage
—
Founded
1997
Headcount
—
HQ
Tel Aviv, Israel
Sector
Biotechnology
About
Ester Neurosciences Ltd. was an Israeli startup focused on developing therapeutic products for neurological disorders such as myasthenia gravis, Alzheimer's disease, multiple sclerosis, and acute stress reactions. Their lead product candidate, EN101, was in Phase IIa clinical development for the treatment of myasthenia gravis. The company utilized a platform messenger RNA (mRNA) silencing technology targeting the cholinergic pathway. Ester Neurosciences was acquired by Amarin Corporation plc in December 2007.
Funding history · 2 rounds · $40.0M total
2007-12
Secondary
$30.0M
★ Yissum★ Amarin Corporation plc★ Aurum Venture MKI Ltd.★ Medica Venture Partners★ Bioville (owned by the Mayer family)Bioville
Date unknown
Seed
$10.0M
★ Yissum★ Aurum Venture MKI Ltd.★ Medica Venture Partners★ Bioville (owned by the Mayer family)
Team · 2
Prof. Hermona Soreq
Founder · CSO
Eli Hazum
CEO
Sectors & technology
Primary sector
Biotechnology
Technologies
Target customers
Business model
Biopharmaceutical
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Ester Neurosciences Limited |
|---|---|
| Founded | 1997 |
Acquisitions & public offerings
Acquired by 2007-12 $30.0M